Literature DB >> 12187174

Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources.

Deborah Schrag1, Peter B Bach, Celia Dahlman, Joan L Warren.   

Abstract

The context in which health care is delivered may have an impact on the outcomes and processes of care. Researchers analyzing claims data that reflect care rendered at many institutions may wish to identify hospital characteristics such as bed size, teaching status, degree of specialization, and case volume to evaluate their influence on outcomes. The authors describe the resources available from administrative data for characterizing hospitals. The article focuses on analyses using the SEER-Medicare-linked data, but has direct relevance for investigators working with other sources of claims data. First, the authors focus on assessment of hospital case volume, which is the principal hospital attribute that can be obtained directly from the SEER-Medicare data files. Second, they assess the information regarding hospital characteristics that can be gleaned from the American Hospital Association (AHA) survey and the annual cost reports submitted to the Center for Medicare and Medicaid Services (CMS) by all certified hospitals. From a comparison of the responses of 4,434 hospitals to 1994 AHA and CMS surveys, the authors conclude that the two data sources contain very similar information, but that for most investigators, use of data from CMS cost reports will be preferable to use of AHA data because of higher survey-completion rates and public availability.

Mesh:

Year:  2002        PMID: 12187174     DOI: 10.1097/00005650-200208001-00013

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  30 in total

1.  Collaboration Between Surgeons and Medical Oncologists and Outcomes for Patients With Stage III Colon Cancer.

Authors:  Tanvir Hussain; Hsien-Yen Chang; Christine M Veenstra; Craig E Pollack
Journal:  J Oncol Pract       Date:  2015-04-14       Impact factor: 3.840

2.  Hospital variation in sphincter preservation for elderly rectal cancer patients.

Authors:  Christopher M Dodgion; Bridget A Neville; Stuart R Lipsitz; Deborah Schrag; Elizabeth Breen; Michael J Zinner; Caprice C Greenberg
Journal:  J Surg Res       Date:  2014-03-22       Impact factor: 2.192

3.  Hospital Case Volume Is Associated With Improved Survival for Patients With Metastatic Melanoma.

Authors:  Jinhai Huo; David R Lairson; Xianglin L Du; Wenyaw Chan; Jing Jiang; Thomas A Buchholz; B Ashleigh Guadagnolo
Journal:  Am J Clin Oncol       Date:  2016-10       Impact factor: 2.339

4.  Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.

Authors:  Xiaotao Zhang; Hashem B El-Serag; Aaron P Thrift
Journal:  Cancer Causes Control       Date:  2021-01-04       Impact factor: 2.506

5.  Outcomes following local therapy for early-stage breast cancer in non-trial populations.

Authors:  Nancy L Keating; Mary Beth Landrum; John M Brooks; Elizabeth A Chrischilles; Eric P Winer; Kara Wright; Rita Volya
Journal:  Breast Cancer Res Treat       Date:  2010-04-08       Impact factor: 4.872

6.  Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital?

Authors:  Hari Nathan; Andrew D Shore; Robert A Anders; Elizabeth C Wick; Susan L Gearhart; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2010-12-21       Impact factor: 3.452

7.  Hospital volume and late survival after cancer surgery.

Authors:  John D Birkmeyer; Yating Sun; Sandra L Wong; Therese A Stukel
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

8.  Volume, process of care, and operative mortality for cystectomy for bladder cancer.

Authors:  Brent K Hollenbeck; Yongliang Wei; John D Birkmeyer
Journal:  Urology       Date:  2007-05       Impact factor: 2.649

9.  Influence of NCI cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients.

Authors:  Tracy Onega; Eric J Duell; Xun Shi; Eugene Demidenko; Daniel Gottlieb; David C Goodman
Journal:  Med Care Res Rev       Date:  2009-05-19       Impact factor: 3.929

10.  Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database.

Authors:  Muhammad Umar Jawad; Sean P Scully
Journal:  J Hematol Oncol       Date:  2009-09-24       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.